AAAAAA

   
Results: 1-25 | 26-28
Results: 1-25/28
VIRION ENCAPSIDATION OF TRNA(3)(LYS)-RIBOZYME CHIMERIC RNAS INHIBITS HIV-INFECTION
Authors: WESTAWAY SK CAGNON L CHANG ZL LI S LI HT LARSON GP ZAIA JA ROSSI JJ
Citation: Sk. Westaway et al., VIRION ENCAPSIDATION OF TRNA(3)(LYS)-RIBOZYME CHIMERIC RNAS INHIBITS HIV-INFECTION, Antisense & nucleic acid drug development, 8(3), 1998, pp. 185-197
COMPARISON OF AMPHOTROPIC AND PSEUDOTYPED VSV-G RETROVIRAL TRANSDUCTION IN HUMAN CD34(-BLOOD PROGENITOR CELLS FROM ADULT DONORS WITH HIV-1 INFECTION OR CANCER() PERIPHERAL)
Authors: YAM PY YEE JK ITO JI SNIECINSKI I DOROSHOW JH FORMAN SJ ZAIA JA
Citation: Py. Yam et al., COMPARISON OF AMPHOTROPIC AND PSEUDOTYPED VSV-G RETROVIRAL TRANSDUCTION IN HUMAN CD34(-BLOOD PROGENITOR CELLS FROM ADULT DONORS WITH HIV-1 INFECTION OR CANCER() PERIPHERAL), Experimental hematology, 26(10), 1998, pp. 962-968
RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND-STUDY OF A CMV GLYCOPROTEIN H-SPECIFIC MONOCLONAL-ANTIBODY (MSL-109) FOR PREVENTION OF CMV INFECTION AFTER ALLOGENEIC HEMATOPOIETIC STEM-CELL TRANSPLANT (HSCT)
Authors: BOECKH M BOWDEN RA CHAO NJ STORER B SPIELBERGER R TIERNEY DK HAWKINS G CUNNINGHAM T LEVITT D ZAIA JA
Citation: M. Boeckh et al., RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND-STUDY OF A CMV GLYCOPROTEIN H-SPECIFIC MONOCLONAL-ANTIBODY (MSL-109) FOR PREVENTION OF CMV INFECTION AFTER ALLOGENEIC HEMATOPOIETIC STEM-CELL TRANSPLANT (HSCT), Bone marrow transplantation, 21, 1998, pp. 477-477
EXPRESSION OF SMALL, THERAPEUTIC RNAS IN HUMAN CELL-NUCLEI
Authors: GOOD PD KRIKOS AJ LI SXL BERTRAND E LEE NS GIVER L ELLINGTON A ZAIA JA ROSSI JJ ENGELKE DR
Citation: Pd. Good et al., EXPRESSION OF SMALL, THERAPEUTIC RNAS IN HUMAN CELL-NUCLEI, Gene therapy, 4(1), 1997, pp. 45-54
EVALUATION OF A QUANTITATIVE PLASMA PCR PLATE ASSAY FOR DETECTING CYTOMEGALOVIRUS-INFECTION IN MARROW TRANSPLANT RECIPIENTS
Authors: GALLEZHAWKINS GM TEGTMEIER BR TERVEER A NILAND JC FORMAN SJ ZAIA JA
Citation: Gm. Gallezhawkins et al., EVALUATION OF A QUANTITATIVE PLASMA PCR PLATE ASSAY FOR DETECTING CYTOMEGALOVIRUS-INFECTION IN MARROW TRANSPLANT RECIPIENTS, Journal of clinical microbiology, 35(3), 1997, pp. 788-790
PLASMA POLYMERASE CHAIN-REACTION FOR CYTOMEGALOVIRUS DNA AFTER ALLOGENEIC MARROW TRANSPLANTATION - COMPARISON WITH POLYMERASE CHAIN-REACTION USING PERIPHERAL-BLOOD LEUKOCYTES, PP65 ANTIGENEMIA, AND VIRAL CULTURE
Authors: BOECKH M GALLEZHAWKINS GM MYERSON D ZAIA JA BOWDEN RA
Citation: M. Boeckh et al., PLASMA POLYMERASE CHAIN-REACTION FOR CYTOMEGALOVIRUS DNA AFTER ALLOGENEIC MARROW TRANSPLANTATION - COMPARISON WITH POLYMERASE CHAIN-REACTION USING PERIPHERAL-BLOOD LEUKOCYTES, PP65 ANTIGENEMIA, AND VIRAL CULTURE, Transplantation, 64(1), 1997, pp. 108-113
LATE CYTOMEGALOVIRUS DISEASE IN MARROW TRANSPLANTATION IS PREDICTED BY VIRUS LOAD IN PLASMA
Authors: ZAIA JA GALLEZHAWKINS GM TEGTMEIER BR TERVEER A LI XL NILAND JC FORMAN SJ
Citation: Ja. Zaia et al., LATE CYTOMEGALOVIRUS DISEASE IN MARROW TRANSPLANTATION IS PREDICTED BY VIRUS LOAD IN PLASMA, The Journal of infectious diseases, 176(3), 1997, pp. 782-785
AMPHOTROPIC AND PSEUDOTYPED VSV-G RETROVIRAL TRANSDUCTION OF CD34-CELLS (HSC) - COMPARISON IN HSC FROM HIV-1-INFECTED AND NONINFECTED SOURCES( HEMATOPOIETIC STEM)
Authors: YAM PY YEE JK ITO JI SNIECINSKI I DOROSHOW JH FORMAN SJ ZAIA JA
Citation: Py. Yam et al., AMPHOTROPIC AND PSEUDOTYPED VSV-G RETROVIRAL TRANSDUCTION OF CD34-CELLS (HSC) - COMPARISON IN HSC FROM HIV-1-INFECTED AND NONINFECTED SOURCES( HEMATOPOIETIC STEM), Blood, 90(10), 1997, pp. 4639-4639
INHIBITION OF HUMAN IMMUNODEFICIENCY VIRUS-1 (HIV-1) REPLICATION AFTER TRANSDUCTION OF GRANULOCYTE-COLONY-STIMULATING FACTOR-MOBILIZED CD34(-1-INFECTED DONORS USING RETROVIRAL VECTORS CONTAINING ANTI-HIV-1 GENES() CELLS FROM HIV)
Authors: BAUER G VALDEZ P KEARNS K BAHNER I WEN SF ZAIA JA KOHN DB
Citation: G. Bauer et al., INHIBITION OF HUMAN IMMUNODEFICIENCY VIRUS-1 (HIV-1) REPLICATION AFTER TRANSDUCTION OF GRANULOCYTE-COLONY-STIMULATING FACTOR-MOBILIZED CD34(-1-INFECTED DONORS USING RETROVIRAL VECTORS CONTAINING ANTI-HIV-1 GENES() CELLS FROM HIV), Blood, 89(7), 1997, pp. 2259-2267
HEMATOPOIETIC POTENTIAL AND RETROVIRAL TRANSDUCTION OF CD34(-1(+) PERIPHERAL-BLOOD STEM-CELLS FROM ASYMPTOMATIC HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1-INFECTED INDIVIDUALS MOBILIZED WITH GRANULOCYTE-COLONY-STIMULATING FACTOR()THY)
Authors: JUNKER U MOON JJ KALFOGLOU CS SNIECINSKI I FORMAN SJ ZAIA JA KANESHIMA H BOHNLEIN E
Citation: U. Junker et al., HEMATOPOIETIC POTENTIAL AND RETROVIRAL TRANSDUCTION OF CD34(-1(+) PERIPHERAL-BLOOD STEM-CELLS FROM ASYMPTOMATIC HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1-INFECTED INDIVIDUALS MOBILIZED WITH GRANULOCYTE-COLONY-STIMULATING FACTOR()THY), Blood, 89(12), 1997, pp. 4299-4306
MOBILIZATION OF PERIPHERAL-BLOOD STEM-CELLS USING G-CSF IN HIV-1-INFECTED PERSONS AND RETROVIRAL TRANSDUCTION EFFICIENCY IN-VITRO
Authors: YAM P ZAIA JA YEE JK LI S SNIECINSKI I FORMAN S ITO J
Citation: P. Yam et al., MOBILIZATION OF PERIPHERAL-BLOOD STEM-CELLS USING G-CSF IN HIV-1-INFECTED PERSONS AND RETROVIRAL TRANSDUCTION EFFICIENCY IN-VITRO, Transfusion, 36(9), 1996, pp. 147-147
NEUTRALIZATION OF HUMAN CYTOMEGALOVIRUS BY HUMAN CD13-SPECIFIC ANTIBODIES
Authors: GIUGNI TD SODERBERG C HAM DJ BAUTISTA RM HEDLUND KO MOLLER E ZAIA JA
Citation: Td. Giugni et al., NEUTRALIZATION OF HUMAN CYTOMEGALOVIRUS BY HUMAN CD13-SPECIFIC ANTIBODIES, The Journal of infectious diseases, 173(5), 1996, pp. 1062-1071
HIV-1 STATUS AND FUNCTION OF G-CSFF-MOBILIZED PERIPHERAL-BLOOD HEMATOPOIETIC STEM-CELLS FROM ASYMPTOMATIC HIV-1-INFECTED INDIVIDUALS - IMPLICATIONS FOR ANTI-HIV GENE-THERAPY
Authors: JUNKER U MOON JJ SNIECINSKI I ZAIA JA BOHNLEIN E KANESHIMA H
Citation: U. Junker et al., HIV-1 STATUS AND FUNCTION OF G-CSFF-MOBILIZED PERIPHERAL-BLOOD HEMATOPOIETIC STEM-CELLS FROM ASYMPTOMATIC HIV-1-INFECTED INDIVIDUALS - IMPLICATIONS FOR ANTI-HIV GENE-THERAPY, Blood, 88(10), 1996, pp. 1074-1074
A RANDOM TRIAL OF 12-WEEK VS 6-WEEK PREEMPTIVE GANCICLOVIR THERAPY INALLOGENEIC MARROW TRANSPLANTATION - INTERIM ANALYSIS
Authors: ZAIA JA CHAO NJ RIZK NW GALLEZHAWKINS GM DAGIS A TERVEER A NILAND JC BLUME KG FORMAN SJ
Citation: Ja. Zaia et al., A RANDOM TRIAL OF 12-WEEK VS 6-WEEK PREEMPTIVE GANCICLOVIR THERAPY INALLOGENEIC MARROW TRANSPLANTATION - INTERIM ANALYSIS, Blood, 88(10), 1996, pp. 1681-1681
LATE CMV DISEASE IN MARROW TRANSPLANTATION IS PREDICTED BY VIRUS LOADIN PLASMA
Authors: GALLEZHAWKINS GM LI X TEGTMEIER BR TERVEER A NILAND JC FORMAN SJ ZAIA JA
Citation: Gm. Gallezhawkins et al., LATE CMV DISEASE IN MARROW TRANSPLANTATION IS PREDICTED BY VIRUS LOADIN PLASMA, Blood, 88(10), 1996, pp. 1688-1688
CYTOMEGALOVIRUS-INFECTION IN THE BONE-MARROW TRANSPLANT RECIPIENT
Authors: ZAIA JA FORMAN SJ
Citation: Ja. Zaia et Sj. Forman, CYTOMEGALOVIRUS-INFECTION IN THE BONE-MARROW TRANSPLANT RECIPIENT, Infectious disease clinics of North America, 9(4), 1995, pp. 879
VACCINE STRATEGIES FOR PREVENTION OF CMV INFECTIONS IN IMMUNOCOMPROMISED ADULTS
Authors: DIAMOND DJ TSUNODA T YORK J WRIGHT C ZAIA JA FORMAN SJ
Citation: Dj. Diamond et al., VACCINE STRATEGIES FOR PREVENTION OF CMV INFECTIONS IN IMMUNOCOMPROMISED ADULTS, Journal of cellular biochemistry, 1995, pp. 295-295
DIRECT DNA IMMUNIZATION OF MICE WITH PLASMID DNA ENCODING THE TEGUMENT PROTEIN PP65 (PPUL83) OF HUMAN CYTOMEGALOVIRUS INDUCES HIGH-LEVELS OF CIRCULATING ANTIBODY TO THE ENCODED PROTEIN
Authors: PANDE H CAMPO K TANAMACHI B FORMAN SJ ZAIA JA
Citation: H. Pande et al., DIRECT DNA IMMUNIZATION OF MICE WITH PLASMID DNA ENCODING THE TEGUMENT PROTEIN PP65 (PPUL83) OF HUMAN CYTOMEGALOVIRUS INDUCES HIGH-LEVELS OF CIRCULATING ANTIBODY TO THE ENCODED PROTEIN, Scandinavian journal of infectious diseases, 1995, pp. 117-120
PROMOTER FOR EXPRESSION OF TRANSDUCED ANTI-HIV AND SIV RIBOZYMES
Authors: ROSSI JJ CARBONNELLE C LI S CHATTERJEE S ZAIA JA LARSON G BERTRAND E
Citation: Jj. Rossi et al., PROMOTER FOR EXPRESSION OF TRANSDUCED ANTI-HIV AND SIV RIBOZYMES, Journal of cellular biochemistry, 1994, pp. 221-221
INHIBITION OF HIV-1 IN HUMAN T-LYMPHOCYTES BY RETROVIRALLY TRANSDUCEDANTI-TAT AND REV HAMMERHEAD RIBOZYMES
Authors: ZHOU C BAHNER IC LARSON GP ZAIA JA ROSSI JJ KOHN DB
Citation: C. Zhou et al., INHIBITION OF HIV-1 IN HUMAN T-LYMPHOCYTES BY RETROVIRALLY TRANSDUCEDANTI-TAT AND REV HAMMERHEAD RIBOZYMES, Gene, 149(1), 1994, pp. 33-39
IDENTIFICATION OF THE MAJOR LATE HUMAN CYTOMEGALOVIRUS MATRIX PROTEINPP65 AS A TARGET ANTIGEN FOR CD8(-SPECIFIC CYTOTOXIC T-LYMPHOCYTES() VIRUS)
Authors: MCLAUGHLINTAYLOR E PANDE H FORMAN SJ TANAMACHI B LI CR ZAIA JA GREENBERG PD RIDDELL SR
Citation: E. Mclaughlintaylor et al., IDENTIFICATION OF THE MAJOR LATE HUMAN CYTOMEGALOVIRUS MATRIX PROTEINPP65 AS A TARGET ANTIGEN FOR CD8(-SPECIFIC CYTOTOXIC T-LYMPHOCYTES() VIRUS), Journal of medical virology, 43(1), 1994, pp. 103-110
COMPARISON OF PLASMA PCR AND BRONCHOALVEOLAR LAVAGE FLUID CULTURE FORDETECTION OF CYTOMEGALOVIRUS-INFECTION IN ADULT BONE-MARROW TRANSPLANT RECIPIENTS
Authors: ASPIN MM GALLEZHAWKINS GM GIUGNI TD TEGTMEIER B LANG DJ SCHMIDT GM FORMAN SJ ZAIA JA
Citation: Mm. Aspin et al., COMPARISON OF PLASMA PCR AND BRONCHOALVEOLAR LAVAGE FLUID CULTURE FORDETECTION OF CYTOMEGALOVIRUS-INFECTION IN ADULT BONE-MARROW TRANSPLANT RECIPIENTS, Journal of clinical microbiology, 32(9), 1994, pp. 2266-2269
USE OF PREEMPTIVE GANCICLOVIR BASED SOLELY ON ASYMPTOMATIC PULMONARY CYTOMEGALOVIRUS-INFECTION IN MARROW TRANSPLANT RECIPIENTS - LONG-TERM FOLLOW-UP
Authors: ZAIA JA SCHMIDT GM CHAO NJ RIZK N NADEMANEE AP NILAND JC HORAK DA LEE J GALLEZHAWKINS G KUSNIERZGLAZ CR ODONNELL MR PARKER PM SNYDER DS SMITH EP STEIN A MOLINA A STEPAN D BLUME KG FORMAN SJ
Citation: Ja. Zaia et al., USE OF PREEMPTIVE GANCICLOVIR BASED SOLELY ON ASYMPTOMATIC PULMONARY CYTOMEGALOVIRUS-INFECTION IN MARROW TRANSPLANT RECIPIENTS - LONG-TERM FOLLOW-UP, Blood, 84(10), 1994, pp. 10000249-10000249
TREATMENT AND PREVENTION OF CYTOMEGALOVIRUS PNEUMONIA AFTER BONE-MARROW TRANSPLANTATION - WHERE DO WE STAND
Authors: FORMAN SJ ZAIA JA
Citation: Sj. Forman et Ja. Zaia, TREATMENT AND PREVENTION OF CYTOMEGALOVIRUS PNEUMONIA AFTER BONE-MARROW TRANSPLANTATION - WHERE DO WE STAND, Blood, 83(9), 1994, pp. 2392-2398
PREVENTION AND TREATMENT OF CYTOMEGALOVIRUS PNEUMONIA IN TRANSPLANT RECIPIENTS
Authors: ZAIA JA
Citation: Ja. Zaia, PREVENTION AND TREATMENT OF CYTOMEGALOVIRUS PNEUMONIA IN TRANSPLANT RECIPIENTS, Clinical infectious diseases, 17, 1993, pp. 190000392-190000399
Risultati: 1-25 | 26-28